Cargando…

Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands

[Image: see text] Toll-like receptors (TLRs) are key pathogen sensors of the immune system. Their activation results in the production of cytokines, chemokines, and costimulatory molecules that are crucial for innate and adaptive immune responses. In recent years, specific (sub)-cellular location an...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Graaff, Michel J., Oosenbrug, Timo, Marqvorsen, Mikkel H. S., Nascimento, Clarissa R., de Geus, Mark A. R., Manoury, Bénédicte, Ressing, Maaike E., van Kasteren, Sander I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303972/
https://www.ncbi.nlm.nih.gov/pubmed/32510940
http://dx.doi.org/10.1021/acs.bioconjchem.0c00237
_version_ 1783548170540679168
author van de Graaff, Michel J.
Oosenbrug, Timo
Marqvorsen, Mikkel H. S.
Nascimento, Clarissa R.
de Geus, Mark A. R.
Manoury, Bénédicte
Ressing, Maaike E.
van Kasteren, Sander I.
author_facet van de Graaff, Michel J.
Oosenbrug, Timo
Marqvorsen, Mikkel H. S.
Nascimento, Clarissa R.
de Geus, Mark A. R.
Manoury, Bénédicte
Ressing, Maaike E.
van Kasteren, Sander I.
author_sort van de Graaff, Michel J.
collection PubMed
description [Image: see text] Toll-like receptors (TLRs) are key pathogen sensors of the immune system. Their activation results in the production of cytokines, chemokines, and costimulatory molecules that are crucial for innate and adaptive immune responses. In recent years, specific (sub)-cellular location and timing of TLR activation have emerged as parameters for defining the signaling outcome and magnitude. To study the subtlety of this signaling, we here report a new molecular tool to control the activation of TLR2 via “click-to-release”-chemistry. We conjugated a bioorthogonal trans-cyclooctene (TCO) protecting group via solid support to a critical position within a synthetic TLR2/6 ligand to render the compound unable to initiate signaling. The TCO-group could then be conditionally removed upon addition of a tetrazine, resulting in restored agonist activity and TLR2 activation. This approach was validated on RAW264.7 macrophages and various murine primary immune cells as well as human cell line systems, demonstrating that TCO-caging constitutes a versatile approach for generating chemically controllable TLR2 agonists.
format Online
Article
Text
id pubmed-7303972
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-73039722020-06-19 Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands van de Graaff, Michel J. Oosenbrug, Timo Marqvorsen, Mikkel H. S. Nascimento, Clarissa R. de Geus, Mark A. R. Manoury, Bénédicte Ressing, Maaike E. van Kasteren, Sander I. Bioconjug Chem [Image: see text] Toll-like receptors (TLRs) are key pathogen sensors of the immune system. Their activation results in the production of cytokines, chemokines, and costimulatory molecules that are crucial for innate and adaptive immune responses. In recent years, specific (sub)-cellular location and timing of TLR activation have emerged as parameters for defining the signaling outcome and magnitude. To study the subtlety of this signaling, we here report a new molecular tool to control the activation of TLR2 via “click-to-release”-chemistry. We conjugated a bioorthogonal trans-cyclooctene (TCO) protecting group via solid support to a critical position within a synthetic TLR2/6 ligand to render the compound unable to initiate signaling. The TCO-group could then be conditionally removed upon addition of a tetrazine, resulting in restored agonist activity and TLR2 activation. This approach was validated on RAW264.7 macrophages and various murine primary immune cells as well as human cell line systems, demonstrating that TCO-caging constitutes a versatile approach for generating chemically controllable TLR2 agonists. American Chemical Society 2020-06-08 2020-06-17 /pmc/articles/PMC7303972/ /pubmed/32510940 http://dx.doi.org/10.1021/acs.bioconjchem.0c00237 Text en Copyright © 2020 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle van de Graaff, Michel J.
Oosenbrug, Timo
Marqvorsen, Mikkel H. S.
Nascimento, Clarissa R.
de Geus, Mark A. R.
Manoury, Bénédicte
Ressing, Maaike E.
van Kasteren, Sander I.
Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands
title Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands
title_full Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands
title_fullStr Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands
title_full_unstemmed Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands
title_short Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands
title_sort conditionally controlling human tlr2 activity via trans-cyclooctene caged ligands
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303972/
https://www.ncbi.nlm.nih.gov/pubmed/32510940
http://dx.doi.org/10.1021/acs.bioconjchem.0c00237
work_keys_str_mv AT vandegraaffmichelj conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands
AT oosenbrugtimo conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands
AT marqvorsenmikkelhs conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands
AT nascimentoclarissar conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands
AT degeusmarkar conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands
AT manourybenedicte conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands
AT ressingmaaikee conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands
AT vankasterensanderi conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands